<DOC>
	<DOC>NCT02649205</DOC>
	<brief_summary>The purpose of this study is to characterise the patient and disease profile under the influence of a protein-restricted diet supplemented with keto acids/amino acids (KA/AA), focusing on the progression of chronic renal insufficiency, calcium and phosphorus metabolism, nutritional status, patient compliance to diet and Ketosteril intake as well as the persistent dietary education to ensure compliance in a large group of pre-dialysis patients.</brief_summary>
	<brief_title>Observational Study on Chronic Kidney Disease Treatment With a Ketosteril Supplemented Protein-restricted Diet</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<criteria>written informed consent nondialyzed patients with CKD indication for Ketosteril according to Summary of Product Characteristics (SmPC), including a glomerular filtration rate (GFR) &lt; 25 mL/min accepted supplemented proteinrestricted diet and newly starting with Ketosteril (treatment naïve, i.e., never treated with Ketosteril before) adult patients ≥ 18 years active cancer diseases pregnancy or breast feeding hypersensitivity to active substances or to any of the excipients in Ketosteril hypercalcaemia major disorder of amino acid metabolism, e.g., hereditary diseases participation in any clinical trial with an investigational drug within 30 days prior to start of study or during the study illiteracy or incapability to read or write</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>